Concepedia
Statistics
Publications
10
Citations
259
H-Index
Active since
1994
Affiliations
Princeton University(Current)
Women's Health Research Institute
Thomas J. Caggiano is an author at Princeton University specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesPhysiologyMedicinal ChemistryImmunologyPharmacotherapyMolecular Pharmacology
Publications per year
1994–2009
A Putative Sirolimus (Rapamycin) Effector Protein
Y.Q. Chen, Hao Chen, A.E. Rhoad et al. · Biochemical and Biophysical Research Communications · 1994 · 77 citations · Full text
Proteinlipid Interaction, Immunology, Molecular Pharmacology +16
Studies on New Acidic Azoles as Glucose-Lowering Agents in Obese, Diabetic db/db Mice
Kenneth L. Kees, Thomas J. Caggiano, Kurt Steiner et al. · Journal of Medicinal Chemistry · 1995 · 48 citations
Combinatorial Chemistry, Bioorganic Chemistry, Insulin Signaling +21
Pyridobenzodiazepines: A novel class of orally active, vasopressin V2 receptor selective agonists
Amedeo Failli, Jay S. Shumsky, Robert J. Steffan et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · Full text
Functional Selectivity, Medicine, Psychotropic Medication +8
WAY-VNA-932
Thomas J. Caggiano · Drugs of the Future · 2002 · 17 citations
Neuropeptides, Functional Selectivity, Medicine +9
The design, synthesis and physical chemical properties of novel human vasopressin V2-receptor antagonists optimized for parenteral delivery
Mark A. Ashwell, Jehan F. Bagli, Thomas J. Caggiano et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 14 citations · Full text
1–5 of 10